Pharmacological and molecular characterization of muscular cholecystokinin receptors in the human lower oesophageal sphincter

Neurogastroenterology and Motility

Volumn 12, Issue 6, 2000, Pages 539-546

  Gonzalez A A ^a   Farre R ^b   Mones J ^a   Capella G ^a   Clave P ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Servei de Patologia Digestiva ^*  (Spain)

Author keywords

CCK agonists; CCK antagonists; Circular muscular strips; LOS pharmacology; Organ bath; Reverse transcription PCR

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ DERIVATIVE; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; COMPLEMENTARY DNA; DESULFOCHOLECYSTOKININ OCTAPEPTIDE; GASTRIN 1; GASTRIN DERIVATIVE; LINTITRIPT; LOXIGLUMIDE; MESSENGER RNA; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN TISSUE; IC 50; LOWER ESOPHAGUS SPHINCTER; MUSCLE CONTRACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BENZODIAZEPINES; BENZODIAZEPINONES; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRIC EMPTYING; GASTRINS; GASTROINTESTINAL AGENTS; GENE EXPRESSION; HORMONE ANTAGONISTS; HUMANS; INDOLEACETIC ACIDS; MALE; MIDDLE AGED; PHENYLUREA COMPOUNDS; PROGLUMIDE; RECEPTORS, CHOLECYSTOKININ; RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SINCALIDE; THIAZOLES;

EID: 0034534001     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2982.2000.00229.x     Document Type: Article

References (36)

1. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors
2. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans
3. The role of the L-Arginine/nitric oxide pathway for relaxation of the human lower esophageal sphincter
4. Effect of cholecystokinin-octapeptide on lower esophageal sphincter
5. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia
6. Regional differences in cholinergic activity of muscle fibers from the human gastroesohageal junction
7. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells
8. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study
9. Molecular cloning, functional expression and cromosomal localization of the human cholecystokinin type A receptor
10. Gastrointestinal hormone receptors and pancreatic cancer
11. Mechanical properties of isolated human esophageal smooth muscle
12. A method for presenting and comparing dose-response curves
13. Mechanism of cholecystokinin inhibition of lower esophageal sphincter pressure
14. Pressor effect of cholecystokinin-octapeptide on the opossum lower esophageal sphincter
15. The action of gastrointestinal polypeptide hormones on the isolated perfused gastroesophageal sphincte
16. Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs
17. Effects of regulatory peptides on the porcine lower oesophageal sphincter
18. Mechanism of action of cholecystokinin octapeptide on cat lower esophageal sphincter
19. Structure-activity relationship of subtypes of cholecystokinin receptors in the cat lower esophageal sphincter
20. The effects of cholecystokinin octapeptide on human isolated alimentary muscle
21. Characterization of cholecystokinin receptors on the human sphincter of Oddi
22. Regulatory peptides in lower esophageal sphincter of pig and man
23. Cholecystokinin receptors
24. G protein-coupled receptors in gastrointestinal physiology I. CCK receptors: An exemplary family
25. Cholecystokinin receptors in human pancreas and gallbladder muscle: A comparative study
26. Peripheral biological activity of SR 27897: A new non-peptide antagonist of CCK(A) receptors
27. Electrophysiological studies of the cholecystokinin(A) receptor antagonist SR 27897B and PD140548 in the rat isolated nodose ganglion
28. Pharmacological characterization of a new potent and specific nonpolypeptidic cholecystokinin antagonist
29. Studies of three nonpeptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum
30. YM022, a highly potent and selective CKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands
31. 2+ mobilization
32. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors
33. Antagonistic effect of YM022, an antiulcer agent in rats, on human cholecystokinin (CCK) B/gastrin receptor
34. YM022 [(R- [2,3dihydro-1 (2'-methylphenacyl)-2-oxo-5-phenyl-1H-benzodiazepin-3-yl]-3-(3-methylphenyl) urea]: An irreversible cholecystokinin type-B receptor antagonist
35. Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach
36. Expression of cholecystokinin A receptors in neurons innervating the rat stomach and intestine